JP2009537218A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537218A5
JP2009537218A5 JP2009510962A JP2009510962A JP2009537218A5 JP 2009537218 A5 JP2009537218 A5 JP 2009537218A5 JP 2009510962 A JP2009510962 A JP 2009510962A JP 2009510962 A JP2009510962 A JP 2009510962A JP 2009537218 A5 JP2009537218 A5 JP 2009537218A5
Authority
JP
Japan
Prior art keywords
medical device
antibody
therapeutic agent
binding site
antigen binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009510962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537218A (ja
Filing date
Publication date
Priority claimed from US11/435,690 external-priority patent/US7572625B2/en
Application filed filed Critical
Publication of JP2009537218A publication Critical patent/JP2009537218A/ja
Publication of JP2009537218A5 publication Critical patent/JP2009537218A5/ja
Pending legal-status Critical Current

Links

JP2009510962A 2006-05-18 2007-05-02 薬物担体高分子でコーティングされた医療用デバイス Pending JP2009537218A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/435,690 US7572625B2 (en) 2006-05-18 2006-05-18 Medical devices coated with drug carrier macromolecules
PCT/US2007/010646 WO2007136516A2 (en) 2006-05-18 2007-05-02 Medical devices coated with drug carrier macromolecules

Publications (2)

Publication Number Publication Date
JP2009537218A JP2009537218A (ja) 2009-10-29
JP2009537218A5 true JP2009537218A5 (cg-RX-API-DMAC10.html) 2010-06-24

Family

ID=38561724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009510962A Pending JP2009537218A (ja) 2006-05-18 2007-05-02 薬物担体高分子でコーティングされた医療用デバイス

Country Status (5)

Country Link
US (1) US7572625B2 (cg-RX-API-DMAC10.html)
EP (1) EP2035052B1 (cg-RX-API-DMAC10.html)
JP (1) JP2009537218A (cg-RX-API-DMAC10.html)
CA (1) CA2652233A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007136516A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8177743B2 (en) 1998-05-18 2012-05-15 Boston Scientific Scimed, Inc. Localized delivery of drug agents
WO2009111716A1 (en) * 2008-03-06 2009-09-11 Boston Scientific Scimed, Inc. Balloon catheter devices with sheath covering
WO2011028419A1 (en) 2009-08-27 2011-03-10 Boston Scientific Scimed, Inc. Balloon catheter devices with drug-coated sheath
US8366661B2 (en) * 2009-12-18 2013-02-05 Boston Scientific Scimed, Inc. Medical device with expandable body for drug delivery by capsules
US8744568B2 (en) * 2009-12-22 2014-06-03 Boston Scientific Scimed, Inc. Medical device with electroactive polymer powered by photovoltaic cell
JP6005729B2 (ja) 2011-04-29 2016-10-12 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. 医療用バルーン、医療用バルーンを備える医療装置およびバルーンを調製する方法
US9217042B2 (en) 2012-10-23 2015-12-22 Abbott Cardiovascular Systems Inc. Method of reducing MACE in diabetic patients subsequent to stent placement

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56135421A (en) * 1980-03-28 1981-10-22 Kyowa Hakko Kogyo Co Ltd Preparation of antitumor composition
US4997913A (en) * 1986-06-30 1991-03-05 Oncogen pH-sensitive immunoconjugates and methods for their use in tumor therapy
US4886062A (en) * 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5059166A (en) * 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia
EP0582595A1 (en) * 1991-04-26 1994-02-16 Surface Active Limited Novel antibodies, and methods for their use
DE69524501T2 (de) * 1994-08-12 2002-05-29 Meadox Medicals, Inc. Mit einen Heparin enhaltendes Kollagendichtmittel imprägniertes Gefässtransplantat
US20060078493A1 (en) * 1998-05-05 2006-04-13 Randolf Von Oepen Methods and apparatus for localized administration of inhibitory moieties to a patient
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
WO2001068158A1 (en) * 2000-03-15 2001-09-20 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US20040047891A1 (en) 2001-02-26 2004-03-11 Sabina Glozman Systems devices and methods for intrabody targeted delivery and reloading of therapeutic agents
JP2005502618A (ja) * 2001-06-04 2005-01-27 ザ・ジェネラル・ホスピタル・コーポレイション 光力学的化合物を用いて脆弱なプラークを検出および治療する方法
WO2003063575A2 (en) * 2002-01-29 2003-08-07 Colb A Mark Endothelialization of vascular surfaces
CN100455275C (zh) 2002-02-06 2009-01-28 祥丰医疗有限公司 包覆有可促进内皮细胞的黏附和分化的包衣的医疗装置
ATE493157T1 (de) 2003-09-15 2011-01-15 Smart Tech Lp Implantate mit befestigten silylierten therapeutischen mitteln
US7858108B2 (en) * 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
CN101141933B (zh) 2004-03-10 2015-07-29 祥丰医疗有限公司 内皮配体结合涂覆的医疗装置
WO2005097186A2 (en) 2004-04-05 2005-10-20 Medivas, Llc Bioactive stents for type ii diabetics and methods for use thereof

Similar Documents

Publication Publication Date Title
Schroeder et al. Multifunctional polyampholyte hydrogels with fouling resistance and protein conjugation capacity
JP2003524772A5 (cg-RX-API-DMAC10.html)
JP2012509886A5 (cg-RX-API-DMAC10.html)
CA2472031A1 (en) Medical device with coating that promotes endothelial cell adherence and differentiation
WO2008060734A3 (en) Nanoparticle compositions
WO2018226578A8 (en) Nectin-4 binding proteins and methods of use thereof
WO2008030706A3 (en) Anti-myostatin antibodies
CY1115731T1 (el) Παραγοντας αναστολης toy mic-1
EP2298346A3 (en) Human antibodies specific to kdr and uses thereof
WO2020065330A3 (en) Chimeric antigen receptor
ATE425777T1 (de) Stents mit wirkstofffreisetzungsbeschichtungen
JP2008531580A5 (cg-RX-API-DMAC10.html)
EP2287201A3 (en) RS7 antibodies
WO2005092925A3 (en) Immunoglobulin variants outside the fc region
JP2009521520A5 (cg-RX-API-DMAC10.html)
JP2008509788A5 (cg-RX-API-DMAC10.html)
JP2010501028A5 (cg-RX-API-DMAC10.html)
Sebra et al. Surface grafted antibodies: controlled architecture permits enhanced antigen detection
JP2006506333A5 (cg-RX-API-DMAC10.html)
WO2007136516A3 (en) Medical devices coated with drug carrier macromolecules
Barrios-Gumiel et al. Dendronized magnetic nanoparticles for HIV-1 capture and rapid diagnostic
JP2008510164A5 (cg-RX-API-DMAC10.html)
WO2008009711A3 (en) Use of soluble cd160 to suppress immunity
Seto et al. Surface modification of siliceous materials using maleimidation and various functional polymers synthesized by reversible addition–fragmentation chain transfer polymerization
Vikholm Self-assembly of antibody fragments and polymers onto gold for immunosensing